Cartesian Therapeutics, Inc. Payments to Acquire Short-term Investments
Cartesian Therapeutics, Inc. (RNAC) reported Payments to Acquire Short-term Investments of $0 for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-12.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireShortTermInvestments · last filed 2021-03-12
- Cartesian Therapeutics, Inc. payments to acquire short-term investments for the quarter ending 2020-12-31 was $0.00.
- Cartesian Therapeutics, Inc. payments to acquire short-term investments for the quarter ending 2020-09-30 was $0.00.
- Cartesian Therapeutics, Inc. payments to acquire short-term investments for the quarter ending 2020-06-30 was $0.00.
- Cartesian Therapeutics, Inc. payments to acquire short-term investments for the quarter ending 2020-03-31 was $0.00, a 100.00% decline year-over-year.
- Cartesian Therapeutics, Inc. payments to acquire short-term investments for fiscal 2020 was $0.00, a 100.00% decline from fiscal 2019.
- Cartesian Therapeutics, Inc. payments to acquire short-term investments for fiscal 2019 was $18.19M, a 16.60% increase from fiscal 2018.
- Cartesian Therapeutics, Inc. payments to acquire short-term investments for fiscal 2018 was $15.60M, a 74.65% decline from fiscal 2017.
- Cartesian Therapeutics, Inc. payments to acquire short-term investments for fiscal 2017 was $61.53M, a 116.52% increase from fiscal 2016.
| Period end | Payments to Acquire Short-term Investments 3 month | Payments to Acquire Short-term Investments 6 month | Payments to Acquire Short-term Investments 9 month | Payments to Acquire Short-term Investments 12 month |
|---|---|---|---|---|
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | $0.00 derived: sum of 2 quarters · filed 2021-03-12 | $0.00 derived: sum of 3 quarters · filed 2021-03-12 | $0.00 10-K · filed 2021-03-12 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $0.00 derived: sum of 2 quarters · filed 2020-11-05 | $0.00 10-Q · filed 2020-11-05 | $0.00 derived: sum of 4 quarters · filed 2021-03-12 |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $0.00 10-Q · filed 2020-08-06 | $0.00 derived: sum of 3 quarters · filed 2021-03-12 | $0.00 derived: sum of 4 quarters · filed 2021-03-12 |
| 2020-03-31 | $0.00 10-Q · filed 2020-05-07 | $0.00 derived: sum of 2 quarters · filed 2021-03-12 | $0.00 derived: sum of 3 quarters · filed 2021-03-12 | $0.00 derived: sum of 4 quarters · filed 2021-03-12 |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | $0.00 derived: sum of 2 quarters · filed 2021-03-12 | $0.00 derived: sum of 3 quarters · filed 2021-03-12 | $18.19M 10-K · filed 2021-03-12 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $0.00 derived: sum of 2 quarters · filed 2020-11-05 | $18.19M 10-Q · filed 2020-11-05 | $18.19M derived: sum of 4 quarters · filed 2021-03-12 |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $18.19M 10-Q · filed 2020-08-06 | $18.19M derived: sum of 3 quarters · filed 2021-03-12 | $19.89M derived: sum of 4 quarters · filed 2021-03-12 |
| 2019-03-31 | $18.19M 10-Q · filed 2020-05-07 | $18.19M derived: sum of 2 quarters · filed 2021-03-12 | $19.89M derived: sum of 3 quarters · filed 2021-03-12 | $19.88M derived: sum of 4 quarters · filed 2021-03-12 |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | $1.70M derived: sum of 2 quarters · filed 2021-03-12 | $1.69M derived: sum of 3 quarters · filed 2021-03-12 | $15.60M 10-K · filed 2021-03-12 |
| 2018-09-30 | $1.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $1.69M derived: sum of 2 quarters · filed 2019-11-08 | $15.60M 10-Q · filed 2019-11-08 | $28.39M derived: sum of 4 quarters · filed 2020-03-12 |
| 2018-06-30 | -$8.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $13.90M 10-Q · filed 2019-08-08 | $26.69M derived: sum of 3 quarters · filed 2020-03-12 | $42.91M derived: sum of 4 quarters · filed 2020-03-12 |
| 2018-03-31 | $13.91M 10-Q · filed 2019-05-09 | $26.70M derived: sum of 2 quarters · filed 2020-03-12 | $42.91M derived: sum of 3 quarters · filed 2020-03-12 | $58.96M derived: sum of 4 quarters · filed 2020-03-12 |
| 2017-12-31 | $12.79M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $29.00M derived: sum of 2 quarters · filed 2020-03-12 | $45.05M derived: sum of 3 quarters · filed 2020-03-12 | $61.53M 10-K · filed 2020-03-12 |
| 2017-09-30 | $16.21M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $32.26M derived: sum of 2 quarters · filed 2018-11-08 | $48.74M 10-Q · filed 2018-11-08 | $53.83M derived: sum of 4 quarters · filed 2019-03-15 |
| 2017-06-30 | $16.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | $32.52M 10-Q · filed 2018-08-08 | $37.62M derived: sum of 3 quarters · filed 2019-03-15 | $60.94M derived: sum of 4 quarters · filed 2019-03-15 |
| 2017-03-31 | $16.47M 10-Q · filed 2018-05-09 | $21.57M derived: sum of 2 quarters · filed 2019-03-15 | $44.89M derived: sum of 3 quarters · filed 2019-03-15 | $41.48M derived: sum of 4 quarters · filed 2019-03-15 |
| 2016-12-31 | $5.10M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-15 | $28.42M derived: sum of 2 quarters · filed 2019-03-15 | $25.00M derived: sum of 3 quarters · filed 2019-03-15 | $28.42M 10-K · filed 2019-03-15 |
| 2016-09-30 | $23.32M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $19.91M derived: sum of 2 quarters · filed 2017-11-07 | $23.32M 10-Q · filed 2017-11-07 | $26.09M derived: sum of 4 quarters · filed 2018-03-15 |
| 2016-06-30 | -$3.41M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-11 | $0.00 10-Q · filed 2017-08-11 | $2.78M derived: sum of 3 quarters · filed 2018-03-15 | |
| 2016-03-31 | $3.41M 10-Q · filed 2017-05-11 | $6.19M derived: sum of 2 quarters · filed 2018-03-15 | ||
| 2015-12-31 | $2.78M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | $3.52M 10-K · filed 2018-03-15 | ||
| 2015-09-30 | $739.00K 10-Q · filed 2016-11-10 | |||
| 2014-12-31 | $0.00 10-K · filed 2017-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |